Insulin Detemir and Pramlintide Interaction

Drug interaction information between Insulin Detemir and Pramlintide.

Insulin Detemir and Pramlintide have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Insulin Detemir and Pramlintide. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Insulin Detemir

Long-Acting Insulin

Drug B

Pramlintide

Amylin Analog

How They Interact

Both drugs lower blood sugar, so taking them together increases the chance of your blood sugar dropping to a dangerous level.

Frequently Asked Questions

What SPL severity band is on file for Insulin Detemir + Pramlintide?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Pramlintide has 13 labeled pairs on file vs Insulin Detemir's 11. In the moderate band specifically: Insulin Detemir has 3 (also Fluoxetine, Octreotide); Pramlintide has 9 (also Insulin Aspart, Insulin Degludec, Insulin Glargine, Insulin Glulisine).

What mechanism field is on file for Insulin Detemir and Pramlintide?

Both drugs lower blood sugar, so taking them together increases the chance of your blood sugar dropping to a dangerous level.

Pramlintide's labeled portfolio outnumbers Insulin Detemir

SPL source-record counts only. This page's band is moderate · classes on file: Insulin Detemir (Long-Acting Insulin); Pramlintide (Amylin Analog).

Insulin Detemir

0 major · 3 moderate · 8 minor · 11 total

Pramlintide

0 major · 9 moderate · 4 minor · 13 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.